DNA Vaccination Primes MHC Class I-Restricted, Simian Virus 40 Large Tumor Antigen-Specific CTL in H-2d Mice That Reject Syngeneic Tumors

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3550-3558

  Schirmbeck, Reinhold ^a   Böhm, Waltraud ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; H2 ANTIGEN; HLA ANTIGEN CLASS 1; VIRUS T ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; DBA MOUSE; FEMALE; GENETICS; GRAFT REJECTION; IMMUNOLOGY; ISOGRAFT; MALE; MOUSE; PLASMID; SARCOMA;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; EPITOPES; FEMALE; GRAFT REJECTION; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; MALE; MAST-CELL SARCOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASM TRANSPLANTATION; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, ISOGENEIC; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 0030587855     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. Schreiber, H. 1993. Tumor immunology. In Fundamental Immunology, 3rd Ed. W. E. Paul, ed. Raven Press, New York, p. 1143.
2. Doherty, P. C., W. Allan, M. Eichelberger, and S. R. Carding. 1992. Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123.
3. 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356:338.
4. Kaufmann, S. H. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129.
5. Tevethia, S. S., D. C. Flyer, and R. Tjian. 1980. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein). Virology 107:13.
6. Staerz, U. D., H. Karasuyama, and A. M. Garner. 1987. Cytotoxic T lymphocytes against a soluble protein. Nature 329:449.
7. Wraith, D. C., A. E. Vessey, and B. A. Askonas. 1987. Purified influenza virus nucleoprotein protects mice from lethal infection. J. Gen. Virol. 68:433.
8. Yewdell, J. W., I. R. Bennink, and Y. Hosaka. 1988. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239:637.
9. + cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide. Eur. J. Immunol. 21:1523.
10. Huang, L., R. Reddy, S. K. Nair, F. Zhou, and B. T. Rouse. 1992. Liposomal delivery of soluble protein antigens for class I MHC-mediated antigen presentation. Res. Immunol. 143:192.
11. Nair, S., X. Zhou, L. Huang, and B. T. Rouse. 1992. Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines. J. Immunol. Methods 152:237.
12. + cytotoxic T lymphocyte responses. J. Immunol. 148:2357.
13. Raychaudhuri, S., M. Tonks, F. Carbone, T. Ryskamp, W. J. Morrow, and N. Hanna. 1992. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc. Natl. Acad. Sci. USA 89:8308.
14. Reddy, R., F. Zhou, S. Nair, L. Huang, and B. T. Rouse. 1992. In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J. Immunol. 148:1585.
15. + cytotoxic T lymphocytes in mice. Eur. J. Immunol. 22:759.
16. + T cell responses without antibody formation. J. Immunol. 149:1334.
17. Zhou, F., B. T. Rouse, and L. Huang. 1992. Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. J. Immunol. 149:1599.
18. Schirmbeck, R., J. Zerrahn, A. Kuhröber, W. Deppert, and J. Reimann. 1993. Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T-antigen (without adjuvants) specifically primes cytotoxic T lymphocytes. Eur. J. Immunol. 23:1528.
19. Bachmann, M. F., T. M. Kündig, G. Freer, Y. Li, C. Y. Kang, D. H. Bishop, H. Hengartner, and R. M. Zinkernagel. 1994. Induction of protective cytotoxic T cells with viral proteins. Eur. J. Immunol 24:2128.
20. Doe, B., K. S. Steimer, and C. M. Walker. 1994. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. Eur. J. Immunol. 24:2369.
21. Schirmbeck, R., W. Böhm, and J. Reimann. 1994. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur. J. Immunol. 24:2068.
22. Schirmbeck, R., K. Melber, T. Mertens, and J. Reimann. 1994. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur. J. Immunol. 24:1088.
23. Ulmer, J. B., J. J. Donnelly, and M. A. Liu. 1994. Presentation of an exogenous antigen by major histocompatibility complex class I molecules. Eur. J. Immunol. 24:1590.
24. + T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J. Immunol. 153:2554.
25. Norbury, C. C., L. J. Hewlett, A. R. Prescott, N. Shastri, and C. Watts. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3:783.
26. Schirmbeck, R., L. Deml, K. Melber, H. Wolf, R. Wagner, and J. Reimann. 1995. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. Vaccine 13:857.
27. Griffiths, J. C., S. J. Harris, G. T. Layton, E. L. Berrie, T. J. French, N. R. Burns. S. E. Adams, and A. J. Kingsman. 1993. Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. J. Virol. 67:3191.
28. Layton, G. T., S. J. Harris, A. J. Gearing, M. Hill Perkins, J. S. Cole, J. C. Griffiths, N. R. Burns, A. J. Kingsman, and S. E. Adams. 1993. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J. Immunol. 151:1097.
29. Schirmbeck, R., K. Melber, T. Mertens, and J. Reimann. 1994. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J. Virol. 68:1418.
30. + cytotoxic T lymphocyte responses in vivo. J. Immunol 152:1110.
31. Pfeifer, J. D., M. J. Wick, R. L. Roberts, K. Findlay, S. J. Normark, and C. V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359.
32. Harding, C. V., and R. Song. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol. 153:4925.
33. Szalay, G., J. Hess, and S. H. Kaufmann. 1994. Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence. Eur. J. Immunol. 24:1471.
34. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:131.
35. Rouse, R. J., S. K. Nair, S. L. Lydy, J. C. Bowen, and B. T. Rouse. 1994. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J. Virol. 68:5685.
36. Davis, H. L., R. Schirmbeck, J. Reimann, and R. G. Whalen. 1995. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to hepatitis B virus surface antigen. Hum. Gene Ther. 6:1447.
37. Lagging, L. M., K. Meyer, D. Hoft, M. Houghton, R. B. Belshe, and R. Ray. 1995. Immune response to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:5859.
38. Martins, L. P., L. L. Lau, M. S. Asano, and R. Ahmed. 1995. DNA vaccination against persistent viral infection. J. Virol. 69:2574.
39. Schirmbeck, R., W. Böhm, K. Ando, F. V. Chisari, and J. Reimann. 1995. Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69:5929.
40. Xiang, Z. Q., and H. C. J. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129.
41. Yokoyama, M., J. Zhang, and J. L. Whitton. 1995. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:2684.
42. Montgomery, D. L., J. W. Shiver, K. R. Leander, H. C. Perry, A. Friedman, D. Martinez, J. B. Ulmer, J. J. Donnelly, and M. A. Liu. 1993. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12:777.
43. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, and A. Friedman. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
44. Ulmer, J. B., R. R. Deck, C. M. DeWitt, A. Friedman, J. J. Donnelly, and M. A. Liu. 1994. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12:1541.
45. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. J. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132.
46. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866.
47. Xu, D., and F. Y. Liew. 1994. Genetic vaccination against leishmaniasis. Vaccine 12:1534.
48. Xu, D., and F. Y. Liew. 1995. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 84:173.
49. Fanning, E., and R. Knippers. 1992. Structure and function of simian virus 40 large tumor antigen. Annu. Rev. Biochem. 61:55.
50. b mutations limit the CTL response to SV40 TASA. J. Immunol. 128:243.
51. Campbell, A. E., F. L. Foley, and S. S. Tevethia. 1983. Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cytotoxic T lymphocyte clones. J. Immunol. 130:490.
52. Anderson, R. W., M. J. Tevethia, D. Kalderon, A. E. Smith, and S. S. Tevethia. 1988. Fine mapping two distinct antigenic sites on simian virus 40 (SV40) T antigen reactive with SV40-specific cytotoxic T-cell clones by using SV40 deletion mutants. J. Virol. 62:285.
53. b-transfected genes by SV40-specific cytotoxic T lymphocytes leads to the abrogation of virus lytic cycle. Virology 162:197.
54. Jennings, S. R., K. L. Fresa, P. A. Lippe, J. E. Milici, and S. S. Tevethia. 1988. Frequency analysis of simian virus 40-specific cytotoxic T lymphocyte precursors in the high responder C57BL/6 mouse strain, J. Virol. 69:2493.
55. Tanaka, Y., and S. S. Tevethia. 1988. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones. J. Immunol. 140:4348.
56. b-restricted cytotoxic T-lymphocyte clones and a synthetic peptide. Virology 171:205.
57. bm mutants. J. Virol. 64:1192.
58. Tevethia, S. S. 1990. Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol. Biol. Med. 7:83.
59. b-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones. J. Immunol. 148:3012.
60. Lill, N. L., M. J. Tevethia, W. G. Hendrickson, and S. S. Tevethia. 1992. Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes. J. Exp. Med. 176:449.
61. b-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen. J. Virol. 69:3134.
62. b restricted determinant in simian virus 40 tumor antigen. J. Virol. 208:159.
63. Pfizenmaier, K., G. Trinchieri, D. Solter, and B. B. Knowles. 1978. Mapping of H-2 genes associated with T cell-mediated cytotoxic responses to SV40-tumour-associated specific antigens. Nature 274:691.
64. Knowles, B. B., M. Koncar, K. Pfizenmaier, D. Solter, D. P. Aden, and G. Trinchieri. 1979. Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen. J. Immunol. 122:1798.
65. Pfizenmaier, K., S. Pan, and B. B. Knowles. 1980. Preferential H-2 association in cytotoxic T cell responses to SV40 tumor-associated specific antigens. J. Immunol. 124:1888.
66. Gooding, L., and K. A. O'Connell. 1983. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. J. Immunol. 131:2580.
67. Bright, R. K., M. H. Shearer, and R. C. Kennedy. 1995. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. J. Immunol. 153:2064.
68. Ljunggren, H.-G., and K. Kärre. 1985. Host resistance directed selectively against H-2 deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 162:1745.
69. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 and 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
70. Kit, S., T. Kurimura, and D. R. Dubbs. 1969. Transplantable mouse tumor line induced by injection of SV40-transformed mouse kidney cells. Int. J. Cancer 4:384.
71. Gurney, E. G., S. Tamowsky, and W. Deppert. 1986. Antigenic binding site of monoclonal antibodies specific for simian virus 40 large T antigen. J. Virol. 57:1168.
72. Schirmbeck, R., and W. Deppert. 1987. Specific interaction of simian virus 40 large T antigen with cellular chromatin and nuclear matrix during the course of lytic infection. J. Virol. 61:3561.
73. von Hoyningen-Huene, V., M. Kurth, and W. Deppert. 1992. Selection against large T-antigen expression in cells transformed by lymphotropic papova virus. Virology 190:155.
74. Artlelt, P., C. Morelle, M. Ausmeier, M. Fitzek, and J. Hauser. 1988. Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection. Gene 68:213.
75. Davis, H. L., B. A. Demeneix, B. Quantin, J. Coulombe, and R. G. Whalen. 1993. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4:733.
76. Davis, H. L., M. L. Michel, and R. G. Whalen. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1847.
77. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548.
78. Ljunggren, H.-G., N. J. Stam, C. Öhlén, J. J. Neefjes, P. Höglund, M.-T. Heemels, J. Bastin, T. N. M. Schuhmacher, A. R. M. Townsend, K. Kärre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
79. Rammensee, H. G., K. Falk, and O. Rötzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213.
80. Shearer, M. H., R. K. Bright, R. E. Lanford, and R. C. Kennedy. 1993. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells. Clin. Exp. Immunol. 91:266.
81. Maki, T., and M. L. Howe. 1976. Primary in vitro sensitization of murine lymphocytes against isogeneic and allogeneic cells transformed by simian virus 40. J. Immunol 117:1398.
82. Warnatz, H., and F. Krapf. 1976. Studies on the specificity of in vitro induced lymphocytoxicity to SV40-transformed fibroblasts. J. Immunol 117:981.
83. b mice. J. Immunol. 156:3687.
84. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
85. + T cells. J. Immunol. 153:2878.
86. Böhm, W., R. Schirmbeck, A. Elbe, K. Melber, D. Diminsky, G. Kraal, N. Van Rooijen, Y. Barenholz, and J. Reimann. 1995. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J. Immunol. 155:3313.
87. Young, J. W., and K. Inaba. 1996. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183:7.
88. Casciola-Rosen, L., A. Rosen, M. Petri, and M. Schissel. 1996. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for co-agulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 93:1624.
89. Huang, A. Y., A. T. Brace, D. M. Pardoll, and H. I. Levitsky. 1996. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J. Exp. Med 183:769.
90. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Leijendekker, C. V. Harding, C. J. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161.
91. Chapes, S. K., and L. R. Goodman. 1985. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors. J. Immunol. 135:2192.
92. Szikora, J.-P., A. van Pel, V. Brichard, M. Andre, N. van Baren, P. Henry, E. de Plaen, and T. Boon. 1990. Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele. EMBO J. 9:1041.
93. Brichard, V. G., G. Warnier, A. van Pel, G. Morlighem, S. Lucas, and T. Boon. 1995. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815. Eur. J. Immunol. 25:664.